1Talley NJ. Dyspepsia management in the millennium : the death of test and treat? Gastroenterology,2002,122 : 1521-1525.
2Okamtot S,Nakano K,Kosahra K,et al. Effects of pravastatin and UDCA on cholesterol and bile acidmetabolism in patients with cholesterol gallstones. J Gastroenterol, 1994,29:47.
3Saunders KD, Catesa JA, Abedn MZ, Lovastatin and gallstone dissolution : a preliminary study. Surgery, 1993,113:28.
1Andersen BN, Scheel J, Rune SJ, Worning H. Exocrine pancreatic function in patients with dyspepsia. Hepatogastroenterology, 1982, 29: 35～37.
2Alvisi V, Bettini L, Blasi A, D'Arienzo A, D'Ambrosi A,Di Simone A, Mangiameli A, Muiesan G, Esposito P,Sollazzo R. Analysis of the symptomatologic components of dyspepsia and their response to treatment with different preparations of ursodeoxycholic acid. Controlled multicenter study. Clin Ter, 1983, 107: 291～295.
3HoltmannG, Gschossmann J, Mayr P, Talley NJ. A randomized placebo-controlled trial of simethicone and cisapride for the treatment of patients with functional dyspepsia. Aliment Pharmacol Ther, 2002, 16:1641 ～1648.
4Salvioli G, Carati L, Lugli R. Steatorrhoea in cirrhosis:effect of ursodeoxycholic acid administration. J Int Med Res, 1990, 18: 289～297.
5Salen G. Clinical perspective on the treatment of gallstones with ursodeoxycholic acid. J Clin Gastroenterol,1988, 10 Suppl 2: S12～S17.
6Suarez F, Levitt MD, Adshead J, Barkin JS. Pancreatic supplements reduce symptomatic response of healthy subjects to a high fat meal. Dig Dis Sci, 1999, 44: 1317～1321.
7Talley NJ. Dyspepsia management in the millennium: the death of test and treat? Gastroenterology, 2002, 122:1521～1525.
8Strid H, Norstrom M, Sjoberg J, et al. Impact of sex and psychological factors on the water loading test in functional dyspepsia. Scand J Gastroenterol, 2001,36:725-730.
9Talley NJ. Drug treatment of functional dyspepsia. Scand J Gastroenterol, 1991,182 (Suppl):47-60.
10Podda M, Zuin M, Dioguardi ML, et al. A combination of chenodeoxycholic acid and ursodeoxycholic acid is more effective than either alone in reducing biliary cholesterol saturation.Hepatology, 1982, 2:334-339.
7Talley NJ. Dyspepsia management in the millennium:the death of teat and treat?. Gastroenterology, 2002, 122(5): 1521-1525.
8Ford AC, Moayyedi P. Current guidelines for dyspepsia management. Dig Dis, 2008, 26(3): 225-230.
9Graham DY, Rugge M. Clinical practice: diagnosis and evaluation of dyspepsia. J Clin Gastroenterol, 2010, 44(3): 167-172.
10Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0[updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
